Multifaceted role of apolipoprotein L1 risk variants and nephropathy
Saved in:
Main Authors: | Mohsen Akhavan Sepahi (Author), Bahram Niknafs (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Two Levels of Podocyte Dysfunctions Induced by Apolipoprotein L1 Risk Variants
by: Etienne Pays
Published: (2024) -
Apolipoprotein E gene polymorphism is not a strong risk factor for diabetic nephropathy and retinopathy in Type I diabetes: case-control study
by: Shcherbak Natalia S
Published: (2001) -
Apolipoprotein E and viral infection: Risks and Mechanisms
by: Feng Chen, et al.
Published: (2023) -
Huperzine A targets Apolipoprotein E: A potential therapeutic drug for diabetic nephropathy based on omics analysis
by: Xiangjun Chen, et al.
Published: (2024) -
Anti-tumorigenic and Platinum-Sensitizing Effects of Apolipoprotein A1 and Apolipoprotein A1 Mimetic Peptides in Ovarian Cancer
by: Aline T. Marinho, et al.
Published: (2019)